SALT LAKE CITY--(BUSINESS WIRE)--Nov. 21, 2007--USANA Health Sciences, Inc. (NASDAQ: USNA) was recently named one of Utah's "Best Companies to Work For" in Utah Business magazine's November cover story. This is the second consecutive year that USANA was recognized by the magazine for providing its employees with a fun, rewarding, and healthy place to work.
Utah Business selected USANA and 11 other Utah-based companies for this recognition, which was based on a rigorous review of each company's benefits and policies as well as a satisfaction survey completed by a large percentage of employees. According to the article, companies that were recognized consider their employees' satisfaction a key component to their success and encourage personal growth in multiple ways.
Utah Business recognized USANA for providing its nearly 600 Utah employees with a culture of health and wellness. Employees enjoy an incredible array of programs and perks that encourage them to live healthier lives, including on-site fitness facilities and a full-time professional trainer, nearly $1,900 of free USANA nutritional products per employee each year, and a corporate cafe that offers healthy alternatives for workday meals.
"USANA is honored to be recognized once again for providing our employees with a stellar workplace," USANA President Dave Wentz said. "We are known around the world for our strong commitment to advancing health and nutrition, a commitment that starts with our employees."
USANA also aims to provide staff members with an unbeatable workplace, including fostering a fun and interesting environment, offering ample opportunities for advancement, and placing real value on employees' talents and ideas.
"Everything from our on-site volleyball court to our annual Halloween family party to our numerous community volunteer opportunities help USANA employees feel appreciated and respected," Wentz concluded. "We truly value everything our employees bring to the table, and we try to show that to them in every way we can."
About USANA
USANA Health Sciences develops and manufactures high-quality nutritionals, personal care, and weight management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Malaysia, Mexico, the Netherlands and the United Kingdom. For more information about USANA, please visit www.usanahealthsciences.com. CONTACT: USANA Health Sciences, Inc.
Dan Macuga, 801-954-7280
Dan.Macuga@us.usana.com
SOURCE: USANA Health Sciences, Inc.
Wednesday, November 21, 2007
Thursday, November 15, 2007
USANA Health Sciences Applauds Sony Ericsson WTA Tour Players' Performance at Season-Ending Championships in Madrid
SALT LAKE CITY--(BUSINESS WIRE)--Nov. 15, 2007--USANA Health Sciences, Inc. (NASDAQ:USNA), the official health supplement supplier of the Sony Ericsson WTA Tour, would like to congratulate Cara Black (ZIM) & Liezel Huber (RSA) for their women's doubles victory Saturday, November 10, at the Sony Ericsson Championships. The popular Sony Ericsson WTA Tour events are viewed by more than four million spectators worldwide. Sunday was the final day of the season-ending Tour Championships that took place in Madrid, Spain.
Black and Huber, the number-one ranked doubles team, had an incredible year on the Sony Ericsson WTA Tour with victories at eight events this season, including their second and third Grand Slam victories at the Australian Open and Wimbledon.
"2007 was a great year for us on the Sony Ericsson WTA Tour," explain Black and Huber. "As a team, we were able to stay focused on our training and our strategy with successful results. We trusted USANA to focus on the quality and purity of our health supplements."
USANA announced its partnership with the Sony Ericsson WTA Tour in late 2006, introducing USANA's unmatched nutritional products to 400 of the world's most elite athletes in women's tennis.
For more information about the Sony Ericsson WTA Tour, please visit http://www.sonyericssonwtatour.com/.
About USANA
USANA Health Sciences develops and manufactures high-quality nutritionals, personal care, and weight management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Malaysia, Mexico, the Netherlands and the United Kingdom. For more information about USANA, please visit http://www.usanahealthsciences.com/.
CONTACT: USANA Health SciencesNetwork Development & Public RelationsDan Macuga, 801-954-7280Dan.Macuga@us.usana.com
SOURCE: USANA Health Sciences
Black and Huber, the number-one ranked doubles team, had an incredible year on the Sony Ericsson WTA Tour with victories at eight events this season, including their second and third Grand Slam victories at the Australian Open and Wimbledon.
"2007 was a great year for us on the Sony Ericsson WTA Tour," explain Black and Huber. "As a team, we were able to stay focused on our training and our strategy with successful results. We trusted USANA to focus on the quality and purity of our health supplements."
USANA announced its partnership with the Sony Ericsson WTA Tour in late 2006, introducing USANA's unmatched nutritional products to 400 of the world's most elite athletes in women's tennis.
For more information about the Sony Ericsson WTA Tour, please visit http://www.sonyericssonwtatour.com/.
About USANA
USANA Health Sciences develops and manufactures high-quality nutritionals, personal care, and weight management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Malaysia, Mexico, the Netherlands and the United Kingdom. For more information about USANA, please visit http://www.usanahealthsciences.com/.
CONTACT: USANA Health SciencesNetwork Development & Public RelationsDan Macuga, 801-954-7280Dan.Macuga@us.usana.com
SOURCE: USANA Health Sciences
Wednesday, October 17, 2007
USANA Health Sciences Inc. Regains Compliance with NASDAQ Listing Standards
SALT LAKE CITY--(BUSINESS WIRE)--Oct. 17, 2007--USANA Health Sciences Inc. (NASDAQ:USNA) announced that a Nasdaq Listing Qualifications Panel has determined the Company is compliant with the continued listing standards of the Nasdaq Stock Market, including the Nasdaq Marketplace Rule 4310(c)(14) related to the filing of periodic reports with the U.S. Securities and Exchange Commission. Accordingly, the Panel has determined that the Company's common stock will continue to be listed on The Nasdaq Stock Market.
USANA filed its amended Form 10-Q on October 10, 2007, which included financial statements as of June 30, 2007 in compliance with SEC regulations related to interim financial statements, and certifications by the Company's Chief Executive and Chief Financial Officers, which were omitted from the original filing.
Gilbert A. Fuller, USANA's Executive Vice President and Chief Financial Officer, said, "The Nasdaq Panel considered the entire record before it, including materials related to adverse publicity directed against USANA, and the resignation of our former accounting firm. The Panel specifically recognized that USANA's Audit Committee completed an investigation of the allegations made by third-party detractors, and that the Audit Committee found no merit to them. The Panel also noted that USANA's new auditor, PricewaterhouseCoopers LLP, undertook a thorough acceptance process before taking on USANA as a new client and completed its review process for the June 30, 2007 Form 10-Q."
The Panel's determination letter dated October 16, 2007, concluded: "Nothing revealed at the hearing raised additional doubts for the Panel about the integrity of management, the Company's business or its regulatory compliance process."
About USANA
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
CONTACT: Investors Contact:USANA Health Sciences Inc.Riley Timmer, Investor Relations, 801-954-7100investor.relations@us.usana.comorMedia Contact:EdelmanJoe Poulos, 312-240-2719
SOURCE: USANA Health Sciences Inc.
USANA filed its amended Form 10-Q on October 10, 2007, which included financial statements as of June 30, 2007 in compliance with SEC regulations related to interim financial statements, and certifications by the Company's Chief Executive and Chief Financial Officers, which were omitted from the original filing.
Gilbert A. Fuller, USANA's Executive Vice President and Chief Financial Officer, said, "The Nasdaq Panel considered the entire record before it, including materials related to adverse publicity directed against USANA, and the resignation of our former accounting firm. The Panel specifically recognized that USANA's Audit Committee completed an investigation of the allegations made by third-party detractors, and that the Audit Committee found no merit to them. The Panel also noted that USANA's new auditor, PricewaterhouseCoopers LLP, undertook a thorough acceptance process before taking on USANA as a new client and completed its review process for the June 30, 2007 Form 10-Q."
The Panel's determination letter dated October 16, 2007, concluded: "Nothing revealed at the hearing raised additional doubts for the Panel about the integrity of management, the Company's business or its regulatory compliance process."
About USANA
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
CONTACT: Investors Contact:USANA Health Sciences Inc.Riley Timmer, Investor Relations, 801-954-7100investor.relations@us.usana.comorMedia Contact:EdelmanJoe Poulos, 312-240-2719
SOURCE: USANA Health Sciences Inc.
Tuesday, October 16, 2007
USANA Health Sciences Announces Third Quarter 2007 Financial Results
-- Earnings Per Share Increased 25.0%, Year-over-Year, to $0.70 --
-- Net Sales Increased 15.5%, Year-over-Year, to $106.2 Million --
SALT LAKE CITY--(BUSINESS WIRE)--Oct. 16, 2007--USANA Health Sciences, Inc. (NASDAQ: USNA) today announced financial results for the fiscal third quarter ending September 29, 2007.
Financial Performance
Net sales in the third quarter of 2007 increased by 15.5% to $106.2 million, compared with $92.0 million in the third quarter of the prior year. Net sales growth for the third quarter of 2007 resulted primarily from a 24.1% net increase in the number of active Associates, meaning those who have purchased products directly from the Company in the preceding three months, either for personal consumption or for resale. Foreign currency fluctuations accounted for 3.4 percentage points of the year-over-year increase in net sales for the third quarter of 2007.
Earnings from continuing operations in the third quarter of 2007 grew by 7.5% to $17.3 million, or 16.3% of net sales, compared with $16.1 million, or 17.5% of net sales, in the third quarter of the prior year. Earnings per share from continuing operations increased by 25.0% in the third quarter of 2007 to $0.70 per share, compared with $0.56 per share in the third quarter of the prior year. This increase was in part due to aggressive stock repurchases and a lower than expected effective tax rate of 31.4%, offsetting higher Selling General and Administrative expenses.
For the nine-month period ended September 29, 2007, consolidated net sales were $314.4 million, an increase of 17.7%, compared with $267.0 million in the first nine months of 2006. Earnings per share from continuing operations increased 22.7% in the first nine months of 2007 to $2.00, compared with $1.63 in the first nine months of 2006.
During the third quarter of 2007, the Company repurchased 180 thousand shares for an investment of $6.6 million. During the first nine months of 2007, the Company repurchased approximately 1.9 million shares for an investment of about $80 million. As of the end of the third quarter, there was about $50 million remaining under the current stock buyback authorization.
Regional Results
During the third quarter of 2007, net sales in North America, the Company's most mature region, increased by 10.1% to $66.6 million, compared with the third quarter of the prior year. This growth was driven primarily by a 16.7% net improvement in the number of active Associates in this region to 105,000. Along with double-digit growth in Canada, sales in Mexico increased by 19.3% over the third quarter of last year.
"We are pleased to have achieved double-digit growth in the number of active Associates and in net sales in the North American region," said Dave Wentz, the Company's President. "Both the Canadian and Mexican markets have contributed to this region's strong sales growth."
During the third quarter of 2007, net sales in the Asia Pacific region increased by 25.7% to $39.6 million, compared with the third quarter of the prior year. The growth in this region was led by double-digit, year-over-year growth in Hong Kong and the Australia-New Zealand markets. Malaysia continues to show steady growth as a new market, contributing $4.9 million of incremental revenue in the third quarter, an 8.6% increase, compared with the second quarter. The number of active Associates in the Asia Pacific region increased by 36.4% to 75,000, compared with 55,000 in the third quarter of the prior year. The number of Associates in our newest market, Malaysia, grew to 12,000 in just its third quarter of operations.
"The Asia Pacific region continues to be a healthy market for USANA," continued Wentz. "This region has been contributing an increasing share of our growth, led by Hong Kong and Australia-New Zealand, and we anticipate that the Malaysian market will play an increasingly important role in this region. We continue to focus the majority of our efforts on solidifying and growing our 13 core markets."
Outlook
Today, the Company is providing financial guidance for the fourth quarter of 2007 and its initial look at the full year 2008. Based on its current business trends, the Company believes that net sales for the fourth quarter of 2007 will be between $108 million and $110 million, a growth rate of 10% to 12%, compared with the prior year fourth quarter.
Earnings per share are expected to be between $0.66 and $0.68 for the fourth quarter of 2007. Accordingly, for the year 2007, sales are now expected to be between $422 million and $424 million, excluding revenues from our discontinued third-party contract manufacturing business, with earnings per share between $2.66 and $2.68.
Additionally, in the Company's first look at full-year 2008, we believe that both net sales and earnings per share will grow 10% to 13%, compared with the full-year 2007. These earnings per share estimates assume an effective tax rate of approximately 36.0% for the fourth quarter of 2007 and for the full-year 2008.
Gilbert A. Fuller, the Company's executive vice president and chief financial officer, said, "Our strategy of supporting our Associates both domestically and internationally, continues to pay off and produce strong financial results. Going forward, we likely will continue to buy back shares as a way of returning value to our shareholders. We are proud to offer the finest nutritional and personal care products in the industry."
Conference Call
USANA will hold a conference call and webcast to discuss this announcement with investors on Wednesday, October 17, 2007 at 11:00 AM ET. Investors may listen to the call by accessing USANA's website at http://www.usanahealthsciences.com.
About USANA
USANA develops and manufactures high quality nutritional, personal care, and weight management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission. USANA Health Sciences, Inc.
Consolidated Statements of Earnings
(In thousands, except per share data)
Quarter Ended
-----------------------
30-Sep-06 29-Sep-07
---------- -----------
(Unaudited) (Unaudited)
Net sales $ 91,967 $106,181
Cost of sales 20,274 21,960
---------- -----------
Gross profit 71,693 84,221
Operating expenses
Associate incentives 36,994 43,021
Selling, general and administrative 17,798 23,053
Research and development 830 864
---------- -----------
Earnings from operations 16,071 17,283
Other income 65 (270)
---------- -----------
Earnings before income taxes 16,136 17,013
Income taxes 5,698 5,350
---------- -----------
Income from continuing operations 10,438 11,663
Income (Loss) from discontinued operations (215) (405)
NET EARNINGS $ 10,223 $ 11,258
========== ===========
Earnings per share - diluted
Continuing operations $ 0.56 $ 0.70
Discontinued operations $ (0.01) $ (0.02)
---------- -----------
Net Earnings $ 0.55 $ 0.68
========== ===========
Weighted average shares outstanding - diluted 18,486 16,613
========== ===========
USANA Health Sciences, Inc.
Consolidated Balance Sheets
(in thousands)
As of As of
30-Dec-06 29-Sep-07
------------ -------------
(Unaudited)
ASSETS
Current Assets
Cash and cash equivalents $ 27,029 $ 11,718
Inventories 22,483 21,058
Other current assets 11,103 12,841
------------ -------------
Total current assets 60,615 45,617
Property and equipment, net 30,323 45,838
Goodwill 5,690 5,690
Other assets 3,374 4,503
------------ -------------
Total assets $ 100,002 $ 101,648
============ =============
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable $ 10,241 $ 7,910
Other current liabilities 29,564 32,507
------------ -------------
Total current liabilities 39,805 40,417
------------ -------------
Long-term liabilities
Line of Credit - 34,625
Other long-term liabilities - 1,673
Stockholders' equity 60,197 24,933
------------ -------------
Total liabilities and stockholders' equity $ 100,002 $ 101,648
============ =============
USANA Health Sciences, Inc.
Sales by Region
(in thousands)
Quarter Ended
---------------------------------
30-Sep-06 29-Sep-07
--------------- ----------------
(Unaudited) (Unaudited)
Region
-----------------------------------
North America
United States $39,425 42.9% $ 42,455 40.0%
Canada 16,574 18.0% 18,792 17.7%
Mexico 4,503 4.9% 5,372 5.1%
------- ------ -------- ------
North America Total 60,502 65.8% $ 66,619 62.8%
Asia Pacific
Australia-New Zealand 12,297 13.4% 14,163 13.3%
Hong Kong 4,582 5.0% 6,876 6.5%
Japan 2,357 2.5% 2,395 2.3%
Taiwan 5,509 6.0% 5,354 5.0%
South Korea 2,117 2.3% 1,634 1.5%
Singapore 4,603 5.0% 4,209 4.0%
Malaysia - 0.0% 4,931 4.6%
------- ------ -------- ------
Asia Pacific Total 31,465 34.2% 39,562 37.2%
------- ------ -------- ------
Consolidated $91,967 100.0% $106,181 100.0%
======= ====== ======== ======
Active Associates by Region
As of
--------------------------------
30-Sep-06 29-Sep-07
--------------- ---------------
(Unaudited) (Unaudited)
Region
------------------------------------
North America
United States 58,000 40.0% 63,000 35.0%
Canada 22,000 15.2% 28,000 15.5%
Mexico 10,000 6.9% 14,000 7.8%
------- ------ ------- ------
North America Total 90,000 62.1% 105,000 58.3%
Asia Pacific
Australia-New Zealand 18,000 12.4% 21,000 11.7%
Hong Kong 8,000 5.5% 13,000 7.2%
Japan 4,000 2.7% 5,000 2.8%
Taiwan 13,000 9.0% 14,000 7.8%
South Korea 2,000 1.4% 2,000 1.1%
Singapore 10,000 6.9% 8,000 4.4%
Malaysia - 0.0% 12,000 6.7%
------- ------ ------- ------
Asia Pacific Total 55,000 37.9% 75,000 41.7%
------- ------ ------- ------
Total 145,000 100.0% 180,000 100.0%
======= ====== ======= ======
Active Preferred Customers by Region
As of
------------------------------
30-Sep-06 29-Sep-07
-------------- --------------
(Unaudited) (Unaudited)
Region
--------------------------------------
North America
United States 49,000 64.5% 51,000 64.6%
Canada 18,000 23.7% 17,000 21.5%
Mexico 2,000 2.6% 3,000 3.8%
------ ------ ------ ------
North America Total 69,000 90.8% 71,000 89.9%
Asia Pacific
Australia-New Zealand 6,000 7.9% 6,000 7.5%
Hong Kong ** 0.0% 1,000 1.3%
Japan 1,000 1.3% 1,000 1.3%
Taiwan ** 0.0% ** 0.0%
South Korea ** 0.0% ** 0.0%
Singapore ** 0.0% ** 0.0%
Malaysia - 0.0% ** 0.0%
------ ------ ------ ------
Asia Pacific Total 7,000 9.2% 8,000 10.1%
------ ------ ------ ------
Total 76,000 100.0% 79,000 100.0%
====== ====== ====== ======
** Count of Active Preferred Customers is less than 500.
CONTACT:USANSA Health SciencesInvestor Relations:Riley Timmer, 801-954-7922investor.relations@us.usana.comorEdelmanJoe Poulos, 312-240-2719
SOURCE: USANA Health Sciences, Inc.
-- Net Sales Increased 15.5%, Year-over-Year, to $106.2 Million --
SALT LAKE CITY--(BUSINESS WIRE)--Oct. 16, 2007--USANA Health Sciences, Inc. (NASDAQ: USNA) today announced financial results for the fiscal third quarter ending September 29, 2007.
Financial Performance
Net sales in the third quarter of 2007 increased by 15.5% to $106.2 million, compared with $92.0 million in the third quarter of the prior year. Net sales growth for the third quarter of 2007 resulted primarily from a 24.1% net increase in the number of active Associates, meaning those who have purchased products directly from the Company in the preceding three months, either for personal consumption or for resale. Foreign currency fluctuations accounted for 3.4 percentage points of the year-over-year increase in net sales for the third quarter of 2007.
Earnings from continuing operations in the third quarter of 2007 grew by 7.5% to $17.3 million, or 16.3% of net sales, compared with $16.1 million, or 17.5% of net sales, in the third quarter of the prior year. Earnings per share from continuing operations increased by 25.0% in the third quarter of 2007 to $0.70 per share, compared with $0.56 per share in the third quarter of the prior year. This increase was in part due to aggressive stock repurchases and a lower than expected effective tax rate of 31.4%, offsetting higher Selling General and Administrative expenses.
For the nine-month period ended September 29, 2007, consolidated net sales were $314.4 million, an increase of 17.7%, compared with $267.0 million in the first nine months of 2006. Earnings per share from continuing operations increased 22.7% in the first nine months of 2007 to $2.00, compared with $1.63 in the first nine months of 2006.
During the third quarter of 2007, the Company repurchased 180 thousand shares for an investment of $6.6 million. During the first nine months of 2007, the Company repurchased approximately 1.9 million shares for an investment of about $80 million. As of the end of the third quarter, there was about $50 million remaining under the current stock buyback authorization.
Regional Results
During the third quarter of 2007, net sales in North America, the Company's most mature region, increased by 10.1% to $66.6 million, compared with the third quarter of the prior year. This growth was driven primarily by a 16.7% net improvement in the number of active Associates in this region to 105,000. Along with double-digit growth in Canada, sales in Mexico increased by 19.3% over the third quarter of last year.
"We are pleased to have achieved double-digit growth in the number of active Associates and in net sales in the North American region," said Dave Wentz, the Company's President. "Both the Canadian and Mexican markets have contributed to this region's strong sales growth."
During the third quarter of 2007, net sales in the Asia Pacific region increased by 25.7% to $39.6 million, compared with the third quarter of the prior year. The growth in this region was led by double-digit, year-over-year growth in Hong Kong and the Australia-New Zealand markets. Malaysia continues to show steady growth as a new market, contributing $4.9 million of incremental revenue in the third quarter, an 8.6% increase, compared with the second quarter. The number of active Associates in the Asia Pacific region increased by 36.4% to 75,000, compared with 55,000 in the third quarter of the prior year. The number of Associates in our newest market, Malaysia, grew to 12,000 in just its third quarter of operations.
"The Asia Pacific region continues to be a healthy market for USANA," continued Wentz. "This region has been contributing an increasing share of our growth, led by Hong Kong and Australia-New Zealand, and we anticipate that the Malaysian market will play an increasingly important role in this region. We continue to focus the majority of our efforts on solidifying and growing our 13 core markets."
Outlook
Today, the Company is providing financial guidance for the fourth quarter of 2007 and its initial look at the full year 2008. Based on its current business trends, the Company believes that net sales for the fourth quarter of 2007 will be between $108 million and $110 million, a growth rate of 10% to 12%, compared with the prior year fourth quarter.
Earnings per share are expected to be between $0.66 and $0.68 for the fourth quarter of 2007. Accordingly, for the year 2007, sales are now expected to be between $422 million and $424 million, excluding revenues from our discontinued third-party contract manufacturing business, with earnings per share between $2.66 and $2.68.
Additionally, in the Company's first look at full-year 2008, we believe that both net sales and earnings per share will grow 10% to 13%, compared with the full-year 2007. These earnings per share estimates assume an effective tax rate of approximately 36.0% for the fourth quarter of 2007 and for the full-year 2008.
Gilbert A. Fuller, the Company's executive vice president and chief financial officer, said, "Our strategy of supporting our Associates both domestically and internationally, continues to pay off and produce strong financial results. Going forward, we likely will continue to buy back shares as a way of returning value to our shareholders. We are proud to offer the finest nutritional and personal care products in the industry."
Conference Call
USANA will hold a conference call and webcast to discuss this announcement with investors on Wednesday, October 17, 2007 at 11:00 AM ET. Investors may listen to the call by accessing USANA's website at http://www.usanahealthsciences.com.
About USANA
USANA develops and manufactures high quality nutritional, personal care, and weight management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission. USANA Health Sciences, Inc.
Consolidated Statements of Earnings
(In thousands, except per share data)
Quarter Ended
-----------------------
30-Sep-06 29-Sep-07
---------- -----------
(Unaudited) (Unaudited)
Net sales $ 91,967 $106,181
Cost of sales 20,274 21,960
---------- -----------
Gross profit 71,693 84,221
Operating expenses
Associate incentives 36,994 43,021
Selling, general and administrative 17,798 23,053
Research and development 830 864
---------- -----------
Earnings from operations 16,071 17,283
Other income 65 (270)
---------- -----------
Earnings before income taxes 16,136 17,013
Income taxes 5,698 5,350
---------- -----------
Income from continuing operations 10,438 11,663
Income (Loss) from discontinued operations (215) (405)
NET EARNINGS $ 10,223 $ 11,258
========== ===========
Earnings per share - diluted
Continuing operations $ 0.56 $ 0.70
Discontinued operations $ (0.01) $ (0.02)
---------- -----------
Net Earnings $ 0.55 $ 0.68
========== ===========
Weighted average shares outstanding - diluted 18,486 16,613
========== ===========
USANA Health Sciences, Inc.
Consolidated Balance Sheets
(in thousands)
As of As of
30-Dec-06 29-Sep-07
------------ -------------
(Unaudited)
ASSETS
Current Assets
Cash and cash equivalents $ 27,029 $ 11,718
Inventories 22,483 21,058
Other current assets 11,103 12,841
------------ -------------
Total current assets 60,615 45,617
Property and equipment, net 30,323 45,838
Goodwill 5,690 5,690
Other assets 3,374 4,503
------------ -------------
Total assets $ 100,002 $ 101,648
============ =============
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable $ 10,241 $ 7,910
Other current liabilities 29,564 32,507
------------ -------------
Total current liabilities 39,805 40,417
------------ -------------
Long-term liabilities
Line of Credit - 34,625
Other long-term liabilities - 1,673
Stockholders' equity 60,197 24,933
------------ -------------
Total liabilities and stockholders' equity $ 100,002 $ 101,648
============ =============
USANA Health Sciences, Inc.
Sales by Region
(in thousands)
Quarter Ended
---------------------------------
30-Sep-06 29-Sep-07
--------------- ----------------
(Unaudited) (Unaudited)
Region
-----------------------------------
North America
United States $39,425 42.9% $ 42,455 40.0%
Canada 16,574 18.0% 18,792 17.7%
Mexico 4,503 4.9% 5,372 5.1%
------- ------ -------- ------
North America Total 60,502 65.8% $ 66,619 62.8%
Asia Pacific
Australia-New Zealand 12,297 13.4% 14,163 13.3%
Hong Kong 4,582 5.0% 6,876 6.5%
Japan 2,357 2.5% 2,395 2.3%
Taiwan 5,509 6.0% 5,354 5.0%
South Korea 2,117 2.3% 1,634 1.5%
Singapore 4,603 5.0% 4,209 4.0%
Malaysia - 0.0% 4,931 4.6%
------- ------ -------- ------
Asia Pacific Total 31,465 34.2% 39,562 37.2%
------- ------ -------- ------
Consolidated $91,967 100.0% $106,181 100.0%
======= ====== ======== ======
Active Associates by Region
As of
--------------------------------
30-Sep-06 29-Sep-07
--------------- ---------------
(Unaudited) (Unaudited)
Region
------------------------------------
North America
United States 58,000 40.0% 63,000 35.0%
Canada 22,000 15.2% 28,000 15.5%
Mexico 10,000 6.9% 14,000 7.8%
------- ------ ------- ------
North America Total 90,000 62.1% 105,000 58.3%
Asia Pacific
Australia-New Zealand 18,000 12.4% 21,000 11.7%
Hong Kong 8,000 5.5% 13,000 7.2%
Japan 4,000 2.7% 5,000 2.8%
Taiwan 13,000 9.0% 14,000 7.8%
South Korea 2,000 1.4% 2,000 1.1%
Singapore 10,000 6.9% 8,000 4.4%
Malaysia - 0.0% 12,000 6.7%
------- ------ ------- ------
Asia Pacific Total 55,000 37.9% 75,000 41.7%
------- ------ ------- ------
Total 145,000 100.0% 180,000 100.0%
======= ====== ======= ======
Active Preferred Customers by Region
As of
------------------------------
30-Sep-06 29-Sep-07
-------------- --------------
(Unaudited) (Unaudited)
Region
--------------------------------------
North America
United States 49,000 64.5% 51,000 64.6%
Canada 18,000 23.7% 17,000 21.5%
Mexico 2,000 2.6% 3,000 3.8%
------ ------ ------ ------
North America Total 69,000 90.8% 71,000 89.9%
Asia Pacific
Australia-New Zealand 6,000 7.9% 6,000 7.5%
Hong Kong ** 0.0% 1,000 1.3%
Japan 1,000 1.3% 1,000 1.3%
Taiwan ** 0.0% ** 0.0%
South Korea ** 0.0% ** 0.0%
Singapore ** 0.0% ** 0.0%
Malaysia - 0.0% ** 0.0%
------ ------ ------ ------
Asia Pacific Total 7,000 9.2% 8,000 10.1%
------ ------ ------ ------
Total 76,000 100.0% 79,000 100.0%
====== ====== ====== ======
** Count of Active Preferred Customers is less than 500.
CONTACT:USANSA Health SciencesInvestor Relations:Riley Timmer, 801-954-7922investor.relations@us.usana.comorEdelmanJoe Poulos, 312-240-2719
SOURCE: USANA Health Sciences, Inc.
Wednesday, October 10, 2007
USANA Health Sciences Inc. Files Amended Form 10-Q for Second Quarter of 2007
SALT LAKE CITY--(BUSINESS WIRE)--Oct. 10, 2007--USANA Health Sciences Inc. (NASDAQ:USNA) announced today that it has filed an amended Form 10-Q with the Securities and Exchange Commission (SEC) and NASDAQ.
The amended report includes financial statements as of June 30, 2007 that comply with the reporting requirements of Regulation S-X and subject to the requirements of Statement of Auditing Standards No. 100. Additionally, the amended report includes the certifications by the Company's Chief Executive and Chief Financial Officers, which were omitted from the original filing. An electronic copy of this amended Form 10-Q can be found at http://www.usanahealthsciences.com.
With the filing of the amended quarterly report, the Company now believes that it is in full compliance with all Form 10-Q filing requirements for continued NASDAQ listing set forth in Marketplace Rule 4310(C)(14).
The Company's Audit Committee appointed PricewaterhouseCoopers, LLP as its new independent registered public accounting firm in early September.
About USANA
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
CONTACT: USANA Health Sciences Inc.Riley Timmer, 801-954-7100 (Investor Relations)investor.relations@us.usana.comorEdelmanJoe Poulos, 312-240-2719
SOURCE: USANA Health Sciences Inc.
The amended report includes financial statements as of June 30, 2007 that comply with the reporting requirements of Regulation S-X and subject to the requirements of Statement of Auditing Standards No. 100. Additionally, the amended report includes the certifications by the Company's Chief Executive and Chief Financial Officers, which were omitted from the original filing. An electronic copy of this amended Form 10-Q can be found at http://www.usanahealthsciences.com.
With the filing of the amended quarterly report, the Company now believes that it is in full compliance with all Form 10-Q filing requirements for continued NASDAQ listing set forth in Marketplace Rule 4310(C)(14).
The Company's Audit Committee appointed PricewaterhouseCoopers, LLP as its new independent registered public accounting firm in early September.
About USANA
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
CONTACT: USANA Health Sciences Inc.Riley Timmer, 801-954-7100 (Investor Relations)investor.relations@us.usana.comorEdelmanJoe Poulos, 312-240-2719
SOURCE: USANA Health Sciences Inc.
Tuesday, October 9, 2007
USANA Schedules Third Quarter 2007 Earnings Release and Conference Call
SALT LAKE CITY--(BUSINESS WIRE)--Oct. 9, 2007--USANA Health Sciences, Inc. (NASDAQ:USNA) today announced that third quarter results will be released after the close of market Tuesday, October 16, 2007. USANA executives will hold a conference call to discuss the announcement with analysts and institutional investors on Wednesday, October 17, 2007 at 11:00 a.m. EDT.
The call will be broadcast over the Internet and can be accessed at http://www.usanahealthsciences.com.
The webcast is also being distributed over Thomson/CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson/CCBN's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in Thomson/CCBN's Individual Investor Network. Institutional investors can access the call via Thomson/CCBN's password-protected event management site, StreetEvents (www.streetevents.com).
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
CONTACT: USANA Health Sciences Inc.Riley Timmer, 801-954-7100investor.relations@us.usana.com
SOURCE: USANA Health Sciences, Inc.
The call will be broadcast over the Internet and can be accessed at http://www.usanahealthsciences.com.
The webcast is also being distributed over Thomson/CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson/CCBN's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in Thomson/CCBN's Individual Investor Network. Institutional investors can access the call via Thomson/CCBN's password-protected event management site, StreetEvents (www.streetevents.com).
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
CONTACT: USANA Health Sciences Inc.Riley Timmer, 801-954-7100investor.relations@us.usana.com
SOURCE: USANA Health Sciences, Inc.
Thursday, September 20, 2007
USANA President Elected Vice Chairman of Direct Selling Association
SALT LAKE CITY--(BUSINESS WIRE)--Sept. 20, 2007--USANA Health Sciences, Inc. (NASDAQ: USNA), today announced that Dave Wentz, president of USANA, was recently elected to a second term as vice chairman of the Direct Selling Association (DSA) Board of Directors and chairman of the Annual Meeting.
As a board officer, Wentz will help direct the DSA, a national trade association of leading companies that manufacture and distribute goods and services sold directly to consumers. USANA is one of more than 200 companies that are DSA members.
"I am proud to work for an organization that plays such an important role in serving and promoting our valuable industry," Wentz said. "The DSA provides an important service to its members and the public through its commitment to ethical business practices and consumer advocacy."
Through more than four years on the DSA board, Wentz has served a variety of roles, including chairman of the Direct Selling Education Foundation and DSA vice chairman for 2006/2007. Wentz also is on the CEO Council of the World Federation of Direct Selling Associations, an affiliate of the DSA that works to support direct selling ethics around the world.
Wentz's work on behalf of direct sales companies and the independent business people they represent has earned the respect and appreciation of his colleagues. "I look forward to continuing my work with Dave Wentz on the DSA Board of Directors," said Nathan Moore, current DSA chairman and general counsel of Mary Kay Inc. "He has played a major part in helping this organization achieve its goals. Working together, I know we will accomplish even more for our industry in the coming year."
DSA President Neil Offen said, "USANA has an excellent reputation among its peers in the Direct Selling Association and provides a great example for our new member companies. USANA's representation on the board is important for our industry's future."
Truman Hunt, chairman of the World Federation of Direct Selling Associations and president & CEO of Nu Skin Enterprises said, "Dave has a great understanding of the industry and its needs, which makes him an excellent choice to help lead this industry into the future."
About the Direct Selling Association
DSA is the national trade association of the leading firms that manufacture and distribute goods and services sold directly to consumers. Among its more than 200 active members are companies selling both via a party-plan method and in the traditional person-to-person style. In 2005, U.S. direct sales exceeded $30 billion with more than 14 million direct sellers nationwide. The vast majority are independent business people - micro-entrepreneurs - whose purpose is to sell the product/service of the company they voluntarily choose to represent. More than 90 percent of direct sellers operate their business part-time.
For more information on direct selling, DSA and its Code of Ethics, please visit the DSA Web site at www.dsa.org.
About USANA
USANA develops and manufactures high-quality nutritional, personal-care, and weight management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Malaysia, Mexico, the Netherlands and the United Kingdom.
More information on USANA can be found at http://www.usanahealthsciences.com.
CONTACT:USANA Health Sciences, Inc.Dan Macuga, 801-954-7280dan.macuga@us.usana.comorEdelmanJoe Poulos, 312-240-2719
SOURCE: USANA Health Sciences, Inc.
As a board officer, Wentz will help direct the DSA, a national trade association of leading companies that manufacture and distribute goods and services sold directly to consumers. USANA is one of more than 200 companies that are DSA members.
"I am proud to work for an organization that plays such an important role in serving and promoting our valuable industry," Wentz said. "The DSA provides an important service to its members and the public through its commitment to ethical business practices and consumer advocacy."
Through more than four years on the DSA board, Wentz has served a variety of roles, including chairman of the Direct Selling Education Foundation and DSA vice chairman for 2006/2007. Wentz also is on the CEO Council of the World Federation of Direct Selling Associations, an affiliate of the DSA that works to support direct selling ethics around the world.
Wentz's work on behalf of direct sales companies and the independent business people they represent has earned the respect and appreciation of his colleagues. "I look forward to continuing my work with Dave Wentz on the DSA Board of Directors," said Nathan Moore, current DSA chairman and general counsel of Mary Kay Inc. "He has played a major part in helping this organization achieve its goals. Working together, I know we will accomplish even more for our industry in the coming year."
DSA President Neil Offen said, "USANA has an excellent reputation among its peers in the Direct Selling Association and provides a great example for our new member companies. USANA's representation on the board is important for our industry's future."
Truman Hunt, chairman of the World Federation of Direct Selling Associations and president & CEO of Nu Skin Enterprises said, "Dave has a great understanding of the industry and its needs, which makes him an excellent choice to help lead this industry into the future."
About the Direct Selling Association
DSA is the national trade association of the leading firms that manufacture and distribute goods and services sold directly to consumers. Among its more than 200 active members are companies selling both via a party-plan method and in the traditional person-to-person style. In 2005, U.S. direct sales exceeded $30 billion with more than 14 million direct sellers nationwide. The vast majority are independent business people - micro-entrepreneurs - whose purpose is to sell the product/service of the company they voluntarily choose to represent. More than 90 percent of direct sellers operate their business part-time.
For more information on direct selling, DSA and its Code of Ethics, please visit the DSA Web site at www.dsa.org.
About USANA
USANA develops and manufactures high-quality nutritional, personal-care, and weight management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Malaysia, Mexico, the Netherlands and the United Kingdom.
More information on USANA can be found at http://www.usanahealthsciences.com.
CONTACT:USANA Health Sciences, Inc.Dan Macuga, 801-954-7280dan.macuga@us.usana.comorEdelmanJoe Poulos, 312-240-2719
SOURCE: USANA Health Sciences, Inc.
Monday, September 17, 2007
USANA Health Sciences to Present at A.G. Edwards' 2nd Annual Emerging Growth Conference
SALT LAKE CITY--(BUSINESS WIRE)--Sept. 17, 2007--USANA Health Sciences, Inc. (NASDAQ: USNA) announced today that it will present at the A.G. Edwards' 2nd Annual Emerging Growth Conference in New York. Gilbert A. Fuller, Executive Vice President and CFO, is scheduled to present to leading institutional investment representatives on Wednesday, September 19, 2007, at 2:45 p.m. ET at the New York Palace Hotel.
Those interested in listening to the webcast may access it through USANA's Web site at http://www.usanahealthsciences.com.
An archived replay of the presentation will also be available approximately one hour following the live presentation at the company's Web site and will remain accessible for 90 days.
About USANA
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
CONTACT: USANA Health Sciences, Inc.
Patrique Richards, 801-954-7100 (Investor Relations)
investor.relations@us.usana.com
SOURCE: USANA Health Sciences, Inc.
Those interested in listening to the webcast may access it through USANA's Web site at http://www.usanahealthsciences.com.
An archived replay of the presentation will also be available approximately one hour following the live presentation at the company's Web site and will remain accessible for 90 days.
About USANA
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
CONTACT: USANA Health Sciences, Inc.
Patrique Richards, 801-954-7100 (Investor Relations)
investor.relations@us.usana.com
SOURCE: USANA Health Sciences, Inc.
Wednesday, September 5, 2007
USANA Health Sciences Inc. Announces Appointment of PricewaterhouseCoopers LLP as New Independent Registered Public Accounting Firm
SALT LAKE CITY, Sep 05, 2007 (BUSINESS WIRE) -- USANA Health Sciences Inc. (NASDAQ:USNA) announced today that it has appointed PricewaterhouseCoopers LLP (PwC) as the Company's new independent registered public accounting firm.
"We are pleased to engage PwC, a global leader in the accounting profession, as our independent auditors," said Ronald S. Poelman, chairperson of the USANA audit committee. "The audit committee had the opportunity to review proposals from several top accounting firms, and we greatly appreciate the efforts of those firms. Ultimately, we chose to engage with PwC both because of their expertise and their global resources. PwC is an ideal match for USANA, given the Company's sustained record of growth in 13 international markets."
"PwC has a history of bringing top-notch talent and professionalism to each of its assignments, and we look forward to working with their team," said Gilbert A. Fuller, USANA's executive vice president and chief financial officer. "We are pleased to be in a position to appoint an independent auditor befitting our status as a global leader in the manufacturing and marketing of high-quality nutritional supplements."
PricewaterhouseCoopers is expected to immediately begin reviewing the Company's financial results filed in USANA's Form 10-Q for the quarter ended June 30, 2007. Once these results have been reviewed, USANA expects to file an amended Form 10-Q with the Securities and Exchange Commission (SEC).
The Company will also file a Form 8-K containing additional information on the engagement of PwC.
About USANA
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
SOURCE: USANA Health Sciences Inc.
USANA
Riley Timmer, Investor Relations, 801-954-7100 investor.relations@us.usana.com
or EdelmanJoe Poulos, 312-240-2719
"We are pleased to engage PwC, a global leader in the accounting profession, as our independent auditors," said Ronald S. Poelman, chairperson of the USANA audit committee. "The audit committee had the opportunity to review proposals from several top accounting firms, and we greatly appreciate the efforts of those firms. Ultimately, we chose to engage with PwC both because of their expertise and their global resources. PwC is an ideal match for USANA, given the Company's sustained record of growth in 13 international markets."
"PwC has a history of bringing top-notch talent and professionalism to each of its assignments, and we look forward to working with their team," said Gilbert A. Fuller, USANA's executive vice president and chief financial officer. "We are pleased to be in a position to appoint an independent auditor befitting our status as a global leader in the manufacturing and marketing of high-quality nutritional supplements."
PricewaterhouseCoopers is expected to immediately begin reviewing the Company's financial results filed in USANA's Form 10-Q for the quarter ended June 30, 2007. Once these results have been reviewed, USANA expects to file an amended Form 10-Q with the Securities and Exchange Commission (SEC).
The Company will also file a Form 8-K containing additional information on the engagement of PwC.
About USANA
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
SOURCE: USANA Health Sciences Inc.
USANA
Riley Timmer, Investor Relations, 801-954-7100 investor.relations@us.usana.com
or EdelmanJoe Poulos, 312-240-2719
Saturday, August 25, 2007
USANA's 15th Anniversary Convention Draws a Record Number of Attendees
USANA Launches New, Fully Customizable HealthPak
SALT LAKE CITY--(BUSINESS WIRE)--Aug. 25, 2007--USANA Health Sciences Inc. (NASDAQ:USNA) announced today that a record number of Associates and guests from each of its 13 international markets attended its 15th annual international convention held in Salt Lake City, Utah, August 22 through August 25.
USANA's annual convention is an opportunity for its independent Associates to attend business and health education seminars while also being recognized for their achievements. This year marks USANA's 15th year of manufacturing high quality, science-based nutritional, personal-care, and weight-management products. As part of the celebration, USANA hosted a concert and fireworks show featuring REO Speedwagon, Juice Newton, and Collin Raye, as well as a golf tournament and 5K run/walk, which helped raise more than $100,000 for international charity Children's Hunger Fund.
At its Thursday morning general session, USANA introduced MyHealthPak, a new, fully customizable packaging system for its supplement products. USANA customers now have the ability to create their own personalized selection of USANA's line of nutritional supplements in daily AM and PM packs, making it convenient to get the nutrition they need every day.
"I believe the strong attendance at our convention this year is a reflection of our continued growth and the true commitment our Associates have to this company," USANA President Dave Wentz said. "I am very excited about the launch of our customized MyHealthPak. This is a product concept I have been looking forward to implementing for many years. It is not only a simple way for customers to get an individualized pack of unique supplements in one convenient package, but it reduces the need for plastic bottles, which is an important part of our commitment to the environment through the USANA Green program."
In addition to the customized MyHealthPak, USANA also announced the following new and enhanced products:
- a reformulation of its BiOmega fish-oil supplement
- new Banana Blast Nutrimeal
- Sense Nutritious Creme Masque
USANA also announced several changes to its award-winning sales materials and business-management tools, including:
USANA develops and manufactures high quality nutritional, personal-care, and weight-management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
CONTACT: USANA Health Sciences Inc. Dan Macuga, 801-954-7280Vice President of Network Development & Public Relationsdan.macuga@us.usana.com
SOURCE: USANA Health Sciences Inc.
SALT LAKE CITY--(BUSINESS WIRE)--Aug. 25, 2007--USANA Health Sciences Inc. (NASDAQ:USNA) announced today that a record number of Associates and guests from each of its 13 international markets attended its 15th annual international convention held in Salt Lake City, Utah, August 22 through August 25.
USANA's annual convention is an opportunity for its independent Associates to attend business and health education seminars while also being recognized for their achievements. This year marks USANA's 15th year of manufacturing high quality, science-based nutritional, personal-care, and weight-management products. As part of the celebration, USANA hosted a concert and fireworks show featuring REO Speedwagon, Juice Newton, and Collin Raye, as well as a golf tournament and 5K run/walk, which helped raise more than $100,000 for international charity Children's Hunger Fund.
At its Thursday morning general session, USANA introduced MyHealthPak, a new, fully customizable packaging system for its supplement products. USANA customers now have the ability to create their own personalized selection of USANA's line of nutritional supplements in daily AM and PM packs, making it convenient to get the nutrition they need every day.
"I believe the strong attendance at our convention this year is a reflection of our continued growth and the true commitment our Associates have to this company," USANA President Dave Wentz said. "I am very excited about the launch of our customized MyHealthPak. This is a product concept I have been looking forward to implementing for many years. It is not only a simple way for customers to get an individualized pack of unique supplements in one convenient package, but it reduces the need for plastic bottles, which is an important part of our commitment to the environment through the USANA Green program."
In addition to the customized MyHealthPak, USANA also announced the following new and enhanced products:
- a reformulation of its BiOmega fish-oil supplement
- new Banana Blast Nutrimeal
- Sense Nutritious Creme Masque
USANA also announced several changes to its award-winning sales materials and business-management tools, including:
- an update to its No. 1 sales tool, the Health & Freedom Newspaper
- enhancements to its presentation software, PresentationPro, including the addition of athlete testimonials
- enhancements to its Downline Management System, allowing for easier reporting and querying capabilities
USANA develops and manufactures high quality nutritional, personal-care, and weight-management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
CONTACT: USANA Health Sciences Inc. Dan Macuga, 801-954-7280Vice President of Network Development & Public Relationsdan.macuga@us.usana.com
SOURCE: USANA Health Sciences Inc.
Subscribe to:
Comments (Atom)
